These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP; JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420 [TBL] [Abstract][Full Text] [Related]
23. [Clinical features of patients with metastatic pheochromocytoma/paraganglioma]. Cui YY; Zhou Y; Gao YJ; Li TY; Wang Y; Zhang WQ; Zhou T; Chen S; Tong AL Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1174-1179. PubMed ID: 38583049 [No Abstract] [Full Text] [Related]
24. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588 [TBL] [Abstract][Full Text] [Related]
25. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324 [TBL] [Abstract][Full Text] [Related]
26. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761 [TBL] [Abstract][Full Text] [Related]
27. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome. Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314 [TBL] [Abstract][Full Text] [Related]
28. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas. Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370 [TBL] [Abstract][Full Text] [Related]
29. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma. Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058 [TBL] [Abstract][Full Text] [Related]
30. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma. Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434 [TBL] [Abstract][Full Text] [Related]
32. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. Brouwers FM; Eisenhofer G; Tao JJ; Kant JA; Adams KT; Linehan WM; Pacak K J Clin Endocrinol Metab; 2006 Nov; 91(11):4505-9. PubMed ID: 16912137 [TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914 [TBL] [Abstract][Full Text] [Related]
34. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea. Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185 [TBL] [Abstract][Full Text] [Related]
36. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation. Kamai T; Murakami S; Arai K; Nishihara D; Uematsu T; Ishida K; Kijima T BMC Cancer; 2022 Mar; 22(1):289. PubMed ID: 35300626 [TBL] [Abstract][Full Text] [Related]
37. SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis. Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946 [TBL] [Abstract][Full Text] [Related]
38. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion. Rijken JA; Niemeijer ND; Corssmit EP; Jonker MA; Leemans CR; Menko FH; Hensen EF Clin Genet; 2016 Jan; 89(1):128-32. PubMed ID: 25827221 [TBL] [Abstract][Full Text] [Related]
39. Surveillance Improves Outcomes for Carriers of SDHB Pathogenic Variants: A Multicenter Study. Davidoff DF; Benn DE; Field M; Crook A; Robinson BG; Tucker K; De Abreu Lourenco R; Burgess JR; Clifton-Bligh RJ J Clin Endocrinol Metab; 2022 Apr; 107(5):e1907-e1916. PubMed ID: 35037935 [TBL] [Abstract][Full Text] [Related]
40. Risk of metastatic pheochromocytoma and paraganglioma in Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]